HEALTH● LOWAug 7 · Aug 7, 2026, 5:16 PM
GLP-1 Drug Linked to Heart Benefits for High-Risk Patients
Human Progress
“Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart attack or stroke, finds a study published by The BMJ today… A total of 52,971 individuals were included […] The post GLP-1 Drug Linked to Heart Benefits for High-Risk Patients appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH43m agoBuruli ulcer in Victoria : How a new mosquito trap trial could stop the spread of flesh - eating bacteriatheage.com.au · AustraliaHEALTH2h ago Evil Dead star Bruce Campbell says he has 5 years to live amid cancer diagnosisnydailynews.com · United StatesHEALTH2h agoIn an era of extreme summers, it’s time to look beyond air conditioningSouth China Morning PostHEALTH5h agoAlzheimer's in people with Down syndrome significantly increases the risk of epilepsyEl Mundo